Whitney Ijem
Stock Analyst at Canaccord Genuity
(4.54)
# 253
Out of 5,124 analysts
115
Total ratings
54%
Success rate
24.75%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Whitney Ijem
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNYA Tenaya Therapeutics | Maintains: Buy | $6 → $5 | $0.74 | +571.23% | 7 | Dec 18, 2025 | |
| PVLA Palvella Therapeutics | Maintains: Buy | $148 → $204 | $90.43 | +125.59% | 8 | Dec 16, 2025 | |
| RYTM Rhythm Pharmaceuticals | Maintains: Buy | $114 → $141 | $99.42 | +41.82% | 10 | Dec 12, 2025 | |
| WVE Wave Life Sciences | Maintains: Buy | $19 → $40 | $15.15 | +164.03% | 2 | Dec 9, 2025 | |
| GUTS Fractyl Health | Maintains: Buy | $6 → $8 | $2.00 | +300.00% | 2 | Nov 21, 2025 | |
| GBIO Generation Bio Co. | Maintains: Buy | $9 → $10 | $5.37 | +86.22% | 3 | Aug 18, 2025 | |
| PASG Passage Bio | Maintains: Buy | $260 → $67 | $18.46 | +262.95% | 7 | Aug 14, 2025 | |
| TSHA Taysha Gene Therapies | Maintains: Buy | $11 → $14 | $5.26 | +166.16% | 11 | Aug 13, 2025 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $136 → $128 | $22.54 | +467.88% | 9 | Aug 8, 2025 | |
| VRTX Vertex Pharmaceuticals | Maintains: Hold | $424 → $411 | $468.38 | -12.25% | 9 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $390 → $415 | $406.40 | +2.12% | 9 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $3.54 | +182.49% | 9 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $74 → $54 | $9.73 | +454.98% | 6 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $68 → $66 | $6.64 | +894.72% | 6 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $148 → $150 | $22.35 | +571.14% | 3 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $93 → $84 | $60.07 | +39.84% | 8 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $121.36 | - | 2 | Jan 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $120 → $240 | $7.38 | +3,154.24% | 4 | Jul 23, 2019 |
Tenaya Therapeutics
Dec 18, 2025
Maintains: Buy
Price Target: $6 → $5
Current: $0.74
Upside: +571.23%
Palvella Therapeutics
Dec 16, 2025
Maintains: Buy
Price Target: $148 → $204
Current: $90.43
Upside: +125.59%
Rhythm Pharmaceuticals
Dec 12, 2025
Maintains: Buy
Price Target: $114 → $141
Current: $99.42
Upside: +41.82%
Wave Life Sciences
Dec 9, 2025
Maintains: Buy
Price Target: $19 → $40
Current: $15.15
Upside: +164.03%
Fractyl Health
Nov 21, 2025
Maintains: Buy
Price Target: $6 → $8
Current: $2.00
Upside: +300.00%
Generation Bio Co.
Aug 18, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $5.37
Upside: +86.22%
Passage Bio
Aug 14, 2025
Maintains: Buy
Price Target: $260 → $67
Current: $18.46
Upside: +262.95%
Taysha Gene Therapies
Aug 13, 2025
Maintains: Buy
Price Target: $11 → $14
Current: $5.26
Upside: +166.16%
Ultragenyx Pharmaceutical
Aug 8, 2025
Maintains: Buy
Price Target: $136 → $128
Current: $22.54
Upside: +467.88%
Vertex Pharmaceuticals
Aug 6, 2025
Maintains: Hold
Price Target: $424 → $411
Current: $468.38
Upside: -12.25%
Aug 1, 2025
Maintains: Buy
Price Target: $390 → $415
Current: $406.40
Upside: +2.12%
Jul 25, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $3.54
Upside: +182.49%
Jun 3, 2025
Maintains: Buy
Price Target: $74 → $54
Current: $9.73
Upside: +454.98%
May 13, 2025
Maintains: Buy
Price Target: $68 → $66
Current: $6.64
Upside: +894.72%
Nov 7, 2024
Maintains: Buy
Price Target: $148 → $150
Current: $22.35
Upside: +571.14%
Oct 30, 2024
Maintains: Hold
Price Target: $93 → $84
Current: $60.07
Upside: +39.84%
Jan 21, 2020
Downgrades: Neutral
Price Target: n/a
Current: $121.36
Upside: -
Jul 23, 2019
Upgrades: Overweight
Price Target: $120 → $240
Current: $7.38
Upside: +3,154.24%